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1. Introduction 
Extracts of embryonic chick muscle contain two 
hemagglutinins, referred to as lectins, that are inhib- 
ited by specific saccharides and that change strikingly 
in specific activity with muscle development [ 1,2]. 
The first to be characterized, a lactose-sensitive agglu- 
tinin here designated lectin-1, is a dimeric protein 
with subunit mol. wt -15 X lo3 [3,4] and is also 
found in other chick tissues [5,6]. Similar proteins 
have been observed in extracts of organs of other spe- 
cies [7 $1. The second lectin from embryonic chick 
muscle, here designated lectin-2, does not agglutinate 
the trypsinized, glutaraldehyde-fixed rabbit erythro- 
cytes used to assay lectin-1 ; but will agglutinate some 
samples of these test cells that had undergone trans- 
formation upon storage in the refrigerator for about 
3 months [2]. The hemagglutination activity of lectin-2 
is insensitive to lactose, but is sensitive to a number 
of saccharides, includingN-acetyl-,D-galactosamine [2]. 
A major impediment to work with lectin-2 was the 
lack of a reliable method for preparing erythrocytes 
that were agglutinated by it. This report describes 
methods for preparing such erythrocytes. It also 
describes the inhibition of lectin-2 activity by low 
concentrations of specific glycosaminoglycans, raising 
the possibility that the lectin might play a role in inter- 
action of developing muscle cells with components of 
the extracellular matrix. 
2. Materials and methods 
2 .l Preparation of type Z erythrocytes 
Trypsin-treated,glutaraldehyde-fixed rabbit erythro- 
cytes, prepared by methods similar to those in [3], are 
referred to as type I erythrocytes. They were stored 
at 6°C as a 10% suspension in 75 mM NaCl. 75 mM 
Na2HP04/KH2P04 (pH 7 2) (PBS) for < 4 weeks. Prior 
to the assay they were diluted with 0.1 M glycine in 
PBS to produce a 4%) suspension. 
2.2. Preparation of type ZZ erythrocytes 
Type II erythrocytes were prepared by transforma- 
tion of type I erythrocytes by incubation under vari- 
ous conditions or by ethanol treatment as described 
in the text. After transformation they were stored as 
a 10% suspension (see table 2). Prior to assay they 
were diluted with 0.1 M glycine in PBS to produce 
a 4% suspension. 
2.3 Hemagglu tination activity 
This was determined using serial 2-fold dilutions 
of extract in microtiter V-plates (Cooke Engineering). 
Each well contained 25 ~1 crythrocyte suspension, 
25 ~1 extract diluted in PBS containing 4 mM 
/3-mercaptoethanol, 2 mM ethylenediaminetetraacetic 
acid (MEPBS), 25 ~1 1% bovine serum albumin in 
0.15 M NaCl and 25 1.11 0.15 M NaCl. To study the 
effects of inhibitors of hemagglutination, appropriate 
concentrations of inhibitor in 0.15 M NaCl were added 
to the well in 25 PI aliquots, replacing the equivalent 
volume of saline. Titers were determined 1 h later. The 
titer is the highest dilution of extract that agglutinated 
the cells (e.g., 1:356). Specific activity is titer-’ (e.g., 
256) divided by mg protein/ml extract. Protein was 
determined by the method in [9]. 
2.4. Preparation of extracts 
These were prepared as described in table 1. 
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2.5. Materials Table 1 
Heparin, heparan sulfate and dermatan sulfate 
were generous gifts of Dr A. Linker, Univ. Utah, 
Salt Lake City. Hyaluronic acid, chondroitin-4-sulfate 
and chondroitin-6-sulfate were obtained from Sigma. 
Saccharides were obtained from l’fantstiehl or Sigma. 
Separation oflectin-I and -2 by high speed centrifugation 
Titer-’ 
Type 1 Type II 
erythrocytes erytheocytes 
Soluble extract 
Supernatant 
256 1024 
3. Results (100 000 x g, 12 h) 256 32 
Pellet 
3 .I. Separation of Iectin-1 from lectin-2 by centrifuga- 
(100000xn,12h) 8 512 
tion 
As a first step in the characterization of lectin-2, it 
was necessary to find a reliable method for preparation 
of erythrocytes that were agglutinated by it. This, in 
turn, required a preparation of lectin-2 devoid of 
lectin-1 activity. We found that upon centrifugation 
of extracts of embryonic chick muscle at 100 000 X g 
for 12 II, all the lectin-1 activity remained in the super- 
natant whereas almost all of the recovered lectin-2 
activity was found in a small pellet at the bottom of 
the centrifuge tube (table 1). This partially purified 
lectin-2 was used for further studies. 
3.2. Preparation and properties of type II erythrocytes 
Our initial preparations of type II erythrocytes 
were spontaneously transformed from type I erythro- 
cytes upon storage in the refrigerator for several 
months [2]. By trial and error we found that higher 
temperatures accelerated this transformation and made 
it much more reliable (table 2). We have no explana- 
tion for this. Since incubation at 60°C was most effec- 
tive (table 2), it is very unlikely that the transforma- 
tion is due to the action of bacterial contaminants or 
to residual enzyme activity in the fixed erythrocytes. 
In the course of these studies we also found that 
treatment with ethanol is a rapid and reliable method 
for transforming type I erythrocytes (table 2). In sub- 
sequent studies we used type II erythrocytes prepared 
by ethanol treatment as described in table 2. 
Pectoral muscle from day 16 chick embryos was homogenized 
for 1 min in a Sorvall Omni-Mixer in 9 vol. MEPBS contain- 
ing 0.1 M lactose and 0.1 M N-acetyl-D-galactosamine and 
centrifuged for 1 h at 100 000 X R. The supernatant (desig- 
nated soluble extract) was then centrifuged for 12 h at 
100 000 X g giving rise to a supernatant and a pellet. The 
latter was resuspended in a volume of MEPBS equal to that 
of the supernatant. Lectin activity was so high that the sugars 
in the homogenizing medium were diluted to non-inhibiting 
concentrations in the serial dilutions of the assay. The type II 
erythrocytes used here had been transformed from type I 
erythrocytes by storage in the refrigerator for 4 months. 
Hemagglutination activity with type 1 erythrocytcs was 
inhibited > 95% by 10 mM lactose and was not affected by 
10 mM N-acetyl-D-galactosamine. Hemagglutination activity 
with type II erythrocytes was inhibited 50% by 10 mM 
N-acetyl-D-galactosamine and was not affected by 10 mM 
lactose 
Display of such ‘type II receptors’ could be determined 
by many factors which control their organization in 
the membrane. 
3.3. Lectin-2 inhibition by glycosaminoglycans 
In an attempt to identify a difference between 
type I and type 11 erythrocytes, we sought to determine 
their relative reactivity with other lectins. In general, 
type II erythrocytes were less agglutinable (table 3). 
This suggests that the difference is related to specific 
binding sites that arc displayed on the type II erythro- 
cytesrather than to a general change in agglutinability. 
Several glycosaminoglycans are potent inhibitors 
of lectin-2 activity (table 4). Heparin and dermatan 
sulfate were c.:v:k;;tently most potent. At 5-fold higher 
concentrations than those in table 4 they inhibited 
> 87.5% of lectin activity. Heparan sulfate was a 
weaker inhibitor and hyaluronic acid, chondroitin4- 
sulfate and chondroitin-6-sulfate had no detectable 
effect at the highest concentrations that could be 
used without interfering with the assay. Assuming 
mol. wt -2 X lo4 for heparin, -10e4 mM produces 
50% inhibition. The most potent simple saccharide 
studied,N-acetyl-D-galactosamine produced 50% 
inhibition at molar concentrations almost 5 orders 
of magnitude higher than heparin. 
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Table 2 
Rate of transformation of type I to type II erythrocytes by different treatments 
Treatment Titer-’ at the indic,ted weeks of incubation 
0.1 0.5 1 2 3 4 12 16 
6°C 0 0 0 0 0 0 512 512 
22°C 0 0 0 0 0 512 512 512 
37°C 0 0 0 512 512 512 512 512 
60°C 0 256 512 512 512 512 512 512 
Ethanol 512 512 512 512 512 512 512 512 
Preparation of type II cells by incubation at different temperatures: Aliquots of 
type I cells were stored as a 10% suspension in PBS at the indicated temperature 
until the observed titer had stabilized. Thereafter they were stored at 6°C. They 
were assayed, after the indicated periods of incubation with aliquots of lcctin-2 
that had been pelleted, as in table 1, resuspended in MEPBS to the initial extract 
volume, and kept frozen in aliquots. A separate aliquot was thawed for testing at 
each time point. Preparation of ethanol-treated type II cells: Type I cells were 
centrifuged at 1000 X g for 5 min and the pellet was resuspended in 9 vol. 100% 
ethanol and gently shaken for 1 h at room temperature. The cells were centrifuged, 
resuspended in 100% ethanol and again shaken for 1 11. The cells were then washed 
5 times in PBS, and stored as a 10% suspension in PBS at room temperature. Titer 
with lectin-2 was maximal within a day of treatment but the wells containing 
relatively high concentrations of Iectin (c.g., dilutions of l/2 to I/16) showed no 
agglutination and only the lower concentrations (l/32 to l/51 2) showed agglutina- 
tion. After several days this ‘high concentration inhibition’ was no longer seen 
Table 3 
Relative agglutination of type I and type II erythrocytes by various lectins 
Lectin Titer-’ 
TYPO I Type II 
erythrocytes erythrocytes (37°C) 
Muscle lectin-1 256 64 4 
Muscle lectin-2 0 256 256 
Concanavalin A 256 128 32 
Wheatgerm agglutinin 256 64 256 
Lentil agglutinin 256 64 16 
Soybean agglutinin 256 64 16 
Type II 
erythrocytes 
(ethanol) 
A concentration of lectin that gave a titer of l/256 with one of the cell prepara- 
tions was determined and the titer with the other cells was determined usinp the 
identical series of lectin dilutions. Lectin-1 was purified by the method in [ 31; 
lectin-2 was obtained by centrifugation for 12 h as in table 1. The other lcctins 
were from commercial sources. Type II erythrocytes were prepared by incubation 
of type I erythrocytes at 37°C or by treatment with ethanol, as described in table 2 
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Table 4 
Inhibition of hemagglutination activity of lectin-2 by 
glycosaminoglycans and other saccharides 
Saccharide Concentration (&ml) inhibiting 
50% of lectin activity 
Heparin 2 
Dermatan sulfate 4 
Heparan sulfate 12 
Chondroitin-4-sulfate > 50 
Chondroitin-6-sulfate > 50 
Hyaluronic acid > 50 
N-acetyl-D-galactosamine 1000 
Cellobiose 2000 
N-acetyl-D-glucosamine > 15 000 
3.4. Lectin-2 in other embryonic chick tissues 
As with lectin-1 [.5,6] we found lectin-2 activity in 
heart, liver and brain of day 16 chick embryos. The 
specific activity of the heart extracts is similar to that 
of pectoral muscle; it is lower in the other tissues. 
4. Discussion 
We have shown [ 1,2] that embryonic muscle 
contains two lectin activities that change with develop- 
ment. A limiting factor in studies of lectin-2 was the 
lack of a reliable method for preparing test erythro- 
cytes. Our finding that treatment of trypsinized, glu- 
taraldehyde-fixed rabbit erythrocytes with ethanol 
produces reliable test cells will facilitate further work. 
Whereas the nature of the transformation by ethanol 
is not known, it should be pointed out that the 
mechanism of generation of test cells that are reactive 
with some other lectins (e.g., by trypsinization) is 
equally obscure. Some possible modifications which 
may sensitize test cells include the exposure of latent 
receptors and the reorganization of certain membrane 
constituents so that receptors are in a more aggluti- 
nable form. 
Lectin-2 is an unusual lectin not only because it 
requires unusual test cells but also because it is present 
in tissue extracts in a high molecular weight form, pre- 
sumably some type of aggregate. This property has per- 
mitted its initial separation from crude extracts by high 
speed centrifugation. However, complete purification 
has not yet been achieved, because of marked activity 
losses with many of the procedures that we used. 
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Another unusual property of lectin-2 is that its 
hemagglutination activity is markedly inhibited by 
specific glycosaminoglycans. Lectin-1 activity is not 
inhibited by these substances. It remains to be deter- 
mined if inhibition of lectin-2 activity is due to inter- 
action of the glycosaminoglycans with its carbohydrate 
binding site. Inhibition does not appear to be a non- 
specific effect of polyanions since other glycosamino- 
glycans have no detectable effect. It is notable that all 
the inhibitory glycosaminoglycans contain some idu- 
ronic acid. The presence of iduronic acid residues in 
glycosaminoglycans has been shown IlO] to correlate 
with their binding to many proteins. However, interac- 
tions between glycosaminoglycans and proteins can 
be highly specific [lo]. The specific hexosamine in the 
glycosaminoglycans does not appear critical for inhib- 
itory activity.N-acetyl-D-galactosamine, an inhibitory 
saccharide, is present in dermatan sulfate an inhibitor; 
but also in chondroitin sulfate and hyaluronic acid. 
Heparin and heparan sulfate, other potent inhibitors, 
contain N-acetyl-D-galactosamine. 
As far as we can determine lectin-2 bears no rela- 
tionship to any known protein that interacts with 
glycosaminoglycans. One protein which interacts with 
heparin is fibronectin [ 1 11. an extracellular protein [ 121 
which has been shown to have hemagglutination 
activity [ 131. One difference between lectin-2 and 
fibronectin is that the hemagglutination activity of 
fibronectin is markedly inhibited by low concentrations 
of EDTA [ 121; but this is routinely present in relatively 
high concentrations in our assay of lectin-2. Fibro- 
nectin is also absent from preparations of lectin-2 that 
we partially purified by adsorption to a cellulose 
column, elution with alkali, and fractionation on 
Sepharose-6B. The product is only purified -20-fold 
and reveals everal protein bands after SDSpolyacryl- 
amide gel electrophoresis under conditions capable of 
resolving fibronectin; but the largest has mol. wt 
42 X 103, far smaller than fibronectin. The possible 
relationship of lectin-2 to a cell surface substance that 
binds heparin and related glycosaminoglycans [14], as 
well as its function in developing tissues, remains to 
be determined. 
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